Applied Therapeutics Stock Alpha and Beta Analysis
| APLT Stock | USD 0.51 0 0.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Applied Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Applied Therapeutics over a specified time horizon. Remember, high Applied Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Applied Therapeutics' market risk premium analysis include:
Beta 1.92 | Alpha (1.01) | Risk 5.73 | Sharpe Ratio (0.21) | Expected Return (1.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Applied |
Applied Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Applied Therapeutics market risk premium is the additional return an investor will receive from holding Applied Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Applied Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Applied Therapeutics' performance over market.| α | -1.01 | β | 1.92 |
Applied Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Applied Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Applied Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Applied Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Applied Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Applied Therapeutics shares will generate the highest return on investment. By understating and applying Applied Therapeutics stock market price indicators, traders can identify Applied Therapeutics position entry and exit signals to maximize returns.
Applied Therapeutics Return and Market Media
The median price of Applied Therapeutics for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 0.62 with a coefficient of variation of 32.49. The daily time series for the period is distributed with a sample standard deviation of 0.24, arithmetic mean of 0.73, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Levi Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. ... | 02/04/2025 |
2 | Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit APLT | 02/07/2025 |
3 | APLT CLASS ACTION REPORT Applied Therapeutics is being Sued for Securities Fraud Investors are Urged to Contact BFA Law by February 18 Deadline | 02/12/2025 |
4 | APLT DEADLINE NOTICE ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadli... | 02/14/2025 |
5 | Applied Therapeutics, Inc. Sued for Securities Law Violations Investors Should Contact Levi Korsinsky Before February 18, 2025 to Discuss Your Rights APLT | 02/18/2025 |
6 | Applied therapeutics COO Constantine Chinoporos sells 196 in stock - Investing.com | 03/06/2025 |
7 | Acquisition by Shoshana Shendelman of 1100000 shares of Applied Therapeutics subject to Rule 16b-3 | 03/10/2025 |
8 | APPLIED THERAPEUTICS Earnings Preview Recent APLT Insider Trading, Hedge Fund Activity, and More - Nasdaq | 03/12/2025 |
About Applied Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Applied or other stocks. Alpha measures the amount that position in Applied Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Interest Debt Per Share | 0.0106 | 0.0101 | Revenue Per Share | 0.11 | 0.096 |
Applied Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Applied Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Applied Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Applied Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Applied Therapeutics. Please utilize our Beneish M Score to check the likelihood of Applied Therapeutics' management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Applied Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.